Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic.

× No keyword cloud information.

46 in total

Review 1. Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection.

Authors: Crispin R Dass
Journal: J Mol Med (Berl) Date: 2004-06-23 Impact factor: 4.599

2. Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration.

Authors: Alessandro Grattoni; Haifa Shen; Daniel Fine; Arturas Ziemys; Jaskaran S Gill; Lee Hudson; Sharath Hosali; Randy Goodall; Xuewu Liu; Mauro Ferrari
Journal: Pharm Res Date: 2010-07-01 Impact factor: 4.200

3. Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects.

Authors: T Klink; C Bela; S Stoelting; S O Peters; R Broll; T Wagner
Journal: J Cancer Res Clin Oncol Date: 2006-06-08 Impact factor: 4.553

Review 4. Combination of celecoxib (Celebrex^®) and CD19 CAR-redirected CTL immunotherapy for the treatment of B-cell non-Hodgkin's lymphomas.

Authors: Tam Nm Dinh; Alexandra S Onea; Ali R Jazirehi
Journal: Am J Clin Exp Immunol Date: 2017-05-15

5. Circulating thrombospondin 1 level as a surrogate marker in patients receiving cyclophosphamide-based metronomic chemotherapy.

Authors: Amélie Lansiaux; Sophie Salingue; Amélie Dewitte; Stéphanie Clisant; Nicolas Penel
Journal: Invest New Drugs Date: 2010-05-07 Impact factor: 3.850

6. Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics.

Authors: Philip Hahnfeldt; Lynn Hlatky; Giannoula Lakka Klement
Journal: Cancer Res Date: 2013-03-14 Impact factor: 12.701

Review 7. Silicon micro- and nanofabrication for medicine.

Authors: Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal: Adv Healthc Mater Date: 2013-04-15 Impact factor: 9.933

Review 8. Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis.

Authors: Gavin Thurston; Nicholas W Gale
Journal: Int J Hematol Date: 2004-07 Impact factor: 2.490

9. Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.

Authors: Mar Creixell; Nicholas A Peppas
Journal: Nano Today Date: 2012-08-01 Impact factor: 20.722

10. Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.

Authors: William Cruz-Munoz; Shan Man; Robert S Kerbel
Journal: Clin Cancer Res Date: 2009-07-21 Impact factor: 12.531

Continuous low-dose anti-angiogenic/ metronomic chemotherapy: from the research laboratory into the oncology clinic.